No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs5749212 |
chr22:31473892-31473893 |
Weak transcription Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
2 |
rs536180417 |
chr22:31473893-31473894 |
Weak transcription Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs5021958 |
chr22:31473896-31473897 |
Weak transcription Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs555816976 |
chr22:31473909-31473910 |
Weak transcription Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs575880222 |
chr22:31473987-31473988 |
Weak transcription Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs146046788 |
chr22:31473999-31474000 |
Weak transcription Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs12158536 |
chr22:31474011-31474012 |
Weak transcription Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
8 |
rs576532885 |
chr22:31474018-31474019 |
Weak transcription Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs62236123 |
chr22:31474019-31474020 |
Weak transcription Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
mRNA abundance
|
10 |
rs150857671 |
chr22:31474042-31474043 |
Weak transcription Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs572727940 |
chr22:31474053-31474054 |
Weak transcription Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs541990754 |
chr22:31474058-31474059 |
Weak transcription Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs62236124 |
chr22:31474089-31474090 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
14 |
rs530829319 |
chr22:31474106-31474107 |
Weak transcription Active TSS Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs183920502 |
chr22:31474107-31474108 |
Weak transcription Active TSS Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs536100965 |
chr22:31474108-31474109 |
Weak transcription Active TSS Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs188656797 |
chr22:31474126-31474127 |
Weak transcription Active TSS Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs145373044 |
chr22:31474129-31474130 |
Weak transcription Active TSS Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs555479793 |
chr22:31474146-31474147 |
Weak transcription Active TSS Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs62236125 |
chr22:31474269-31474270 |
Weak transcription Enhancers Flanking Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
21 |
rs114060024 |
chr22:31474328-31474329 |
Weak transcription Enhancers Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs536092493 |
chr22:31474340-31474341 |
Weak transcription Enhancers Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs549546336 |
chr22:31474348-31474349 |
Weak transcription Enhancers Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs569499055 |
chr22:31474386-31474387 |
Weak transcription Enhancers Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs538484307 |
chr22:31474483-31474484 |
Weak transcription Enhancers Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs9609218 |
chr22:31474500-31474501 |
Weak transcription Enhancers Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs55830971 |
chr22:31474515-31474516 |
Weak transcription Enhancers Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
28 |
rs12330058 |
chr22:31474554-31474555 |
Weak transcription Enhancers Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
29 |
rs62236126 |
chr22:31474598-31474599 |
Weak transcription Enhancers Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
30 |
rs10854603 |
chr22:31474657-31474658 |
Weak transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
31 |
rs180828347 |
chr22:31474664-31474665 |
Weak transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs541703433 |
chr22:31474688-31474689 |
Weak transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs186119307 |
chr22:31474717-31474718 |
Weak transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs573318430 |
chr22:31474741-31474742 |
Weak transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs189499413 |
chr22:31474775-31474776 |
Weak transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs544458142 |
chr22:31474791-31474792 |
Weak transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs369201475 |
chr22:31474841-31474842 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs372049316 |
chr22:31474842-31474843 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs561562826 |
chr22:31474843-31474844 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs35660737 |
chr22:31474865-31474866 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs556876356 |
chr22:31474868-31474869 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs372624726 |
chr22:31474873-31474874 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs564497121 |
chr22:31474899-31474900 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs181932912 |
chr22:31474919-31474920 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs148842586 |
chr22:31474930-31474931 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs547003822 |
chr22:31474965-31474966 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs560610951 |
chr22:31474975-31474976 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs116416395 |
chr22:31474982-31474983 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs549314979 |
chr22:31474997-31474998 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs535848940 |
chr22:31475040-31475041 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|